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RNA-based viral immunity (RVI) operates in fungi, plants, and invertebrates to specifically destroy viral RNAs
using the cellular RNA interference machinery. Discovery of diverse viral proteins as suppressors of RNA
silencing provides strong validation for the effectiveness of RVI. Here we review recent studies that have
revealed new mechanistic insights into plant and insect viral suppressors of RVI or suggested a role for
RNA silencing suppression during mammalian viral infection.Introduction
RNA silencing controls antiviral immunity in diverse eukaryotes
including fungi, plants, and invertebrates. In this RNA-based
virus immunity (RVI), virus-specific dsRNA produced during
infection is processed by a Dicer type III nuclease (RNase III)
into siRNAs, which are then loaded onto an Argonaute protein
(AGO) to guide specific viral clearancebyRNAsilencing (Figure 1)
(Ruiz-Ferrer and Voinnet, 2009). Consistent with an antiviral role
for RNA silencing, many plant and animal viruses have been
shown to encode a viral suppressor of RNA silencing (VSR).
VSR activity is detectable during assays with experimental RNA
silencing induced by exogenous dsRNA or an overexpressed
sense RNA transgene (Li and Ding, 2006). However, VSRs play
an important role in the context of viral pathogenesis. Recent
studies have demonstrated rescue of VSR-deficient mutant
viruses in plant and insect host cells which are defective in RNA
silencing, thereby establishing a specific role for active viral
suppression of RVI during infection. In this review, we highlight
several VSRs whose host targets have been recently defined.
AGO-Targeting VSRs
AGOs are key players in RNA silencing because all three classes
of small silencing RNAs, siRNAs, microRNAs (miRNAs), and
Piwi-interacting RNAs, guide silencing only after their specific
binding to an AGO. Some AGOs cleave/slice the target RNA by
the RNase H-like Piwi domain in the RNA-induced silencing
complex (RISC), whereas others recruit additional proteins into
effector complexes to mediate either translational repression
or transcriptional silencing. AGOs which are known to direct
RVI in Arabidopsis thaliana (AGO1), Drosophila melanogaster
(Ago-2), and Caenorhabditis elegans (RDE-1) all exhibit the slicer
activity (Ruiz-Ferrer and Voinnet, 2009).
The first VSR shown to bind an AGO in vivo is the 2b protein of
positive-strand (+) RNA genome carrying Cucumber mosaic
virus (CMV) (Zhang et al., 2006). Of the ten AGOs encoded by
A. thaliana, AGO1 is the major one involved in cytoplasmic RNA
silencing by both siRNAs and miRNAs. AGO1 contributes to
RVI against CMV since ago1mutant plants are hypersusceptible
to CMV and AGO1 immunoprecipitates contain CMV siRNAs
(Ruiz-Ferrer and Voinnet, 2009; Zhang et al., 2006). Interaction12 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.of the viral 2b protein with AGO1 in A. thaliana plants infected
with CMV was shown to inhibit in vitro slicing of the target RNA
by siRNA-programmed AGO1 (Figure 1). However, 2b also binds
long dsRNA and siRNA duplexes in vitro (Goto et al., 2007). In in-
fected plants, host RNA-directed RNA polymerase (RDR)1 or
RDR6 synthesizes virus-specific dsRNA which are then pro-
cessed into viral secondary siRNAs. These siRNAs been recently
shown to play an essential role in RVI against CMV (Ruiz-Ferrer
and Voinnet, 2009; Wang et al., 2010), and the viral 2b protein
can inhibit production of viral secondary siRNAs (Diaz-Pendon
et al., 2007). Future studies will be necessary to determine how
2bbinding to AGO1and/or to duplexRNA interfereswith produc-
tion of viral secondary siRNAs.
Suppression of RNA silencing by P0 encoded by the (+)RNA
genome of poleorviruses is associated with specific degradation
of AGO1 in tobacco (Nicotiana benthamiana) plants (Baum-
berger et al., 2007; Bortolamiol et al., 2007). P0 is an F box
protein that interacts with the A. thaliana homolog of the S phase
kinase-related protein 1 (SKP1), a protein in the proteasome
pathway, in a manner dependent on the integrity of P0s
N-terminal F-box. However, P0-mediated AGO1 degradation is
insensitive to proteosome inhibition, which is inconsistent with
the idea that AGO1 is targeted by P0 for ubiquitynation and pro-
teasome-dependent degradation. Further, P0 does not appear
to interact directly with AGO1 (Bortolamiol et al., 2007; Csorba
et al., 2010). However, both P0 and a P0 mutant that carries
mutations in the F-box and is defective in silencing suppression
were detected in the high molecular weight AGO1-containing
RISC-like complex, indicating that P0 interactswith a component
of RISC in an F-box-independent manner (Figure 1) (Csorba
et al., 2010). However, P0 exhibited VSR activity only when it is
expressed before RISC assembly and did not inhibit the activity
of mature RISC preloaded with either a host miRNA or viral
siRNAs (Csorba et al., 2010). Based on these observations,
Csorba and colleagues propose that P0 binding to a component
of RISC prevents loading of siRNAs into AGO1 during RISC
assembly and AGO1 not assembled into RISC is readily
degraded. However, this model does not include a possible
role for the recognition of P0 by the SKP1 complex in the VSR
activity and/or AGO1 degradation.
Figure 1. Mechanisms in the Viral Suppression of RNA-Based Viral
Immunity
VSRs target RNA and protein components of the RNA silencing pathway and
inhibit siRNA production (B2, P6), RISC assembly (P0 and possibly P38),
slicing activity of mature RISC (P1, 1A), amplification of viral secondary siRNAs
(2b, RNaseIII (R3), V2), or intercellular movement of viral siRNAs (P19).
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AGO whereby the virus mimics the cellular glycine/tryptophane
(GW)/WG repetitive motif (Azevedo et al., 2010; Giner et al.,
2010). The GW/WG motif is encoded by cellular proteins of fruit
fly and fission yeast that are recruited by Ago-1 to the RISC and
RNA-induced transcriptional silencing complex, respectively, to
repress translation by miRNAs and to silence transcription near
centromeres. Thus a GW/WG motif can serve as an ‘‘AGO
hook.’’ Azevedo and colleagues show that the P38 VSR protein
of turnip crinkle virus (TCV), a (+)RNA virus, contains two discrete
GW repeats and interacts directly with A. thaliana AGO1 but not
AGO4 (Azevedo et al., 2010). Direct AGO1 binding to the indi-
vidual N-terminal and C-terminal GW motifs of P38 in vitro was
also detected, and the interaction was abolished by changing
GW to GA. Several lines of evidence indicate that expression
of P38 in TCV-infected plants inhibits the activities of AGO1 in
A. thaliana (Figure 1). For example, GA mutation in both GW
repeats of P38 abolished its VSR activity, and TCV carrying
two GA mutations (TCVGA2) was partially rescued in ago1-27
mutant plants. Moreover, the AGO1-dependent accumulation
of host miRNAs was dramatically reduced in TCV-infected
plants, phenocopying hypomorphic ago1-27 mutant plants and
indicating that AGO-1 was targeted during infection (Azevedo
et al., 2010). However, a previous study reported no significant
reduction in host miRNAs in A. thaliana plants carrying an over-
expressing P38 transgene (Ruiz-Ferrer and Voinnet, 2009). It is
not clear if P38 binding of AGO1 acts to prevent AGO1 from
being assembled into mature RISC or if it blocks the silencing
activity of the AGO1-containing mature RISC. It is also not clear
if the activity of P38 to bind siRNA and long dsRNA, as observed
previously (Merai et al., 2006), plays a role in its bnding to AGO1.
It is of interest to note that infection of TCVGA2 was rescued lesseffectively by ago1-27 mutation than by double loss-of-function
mutations in both Dicer-like (DCL)2 and DCL4 (Azevedo et al.,
2010), which produce 22 and 21 nucleotide viral siRNAs acting
redundantly to guide RVI (Ruiz-Ferrer and Voinnet, 2009), sug-
gesting participation of additional an AGO (or AGOs) in RVI and
targeted by P38.
Giner and colleagues found the VSR of the (+)RNA virus sweet
potato mild mottle virus (SPMMV), P1, contains three GW/WG
repeats (Giner et al., 2010). Based on transient overexpression
in a heterologous system (N. benthamiana leaves), the authors
show that P1 bound to A. thaliana AGO1 and cofractionated
with both AGO1 and host miRNAs in a high molecular weight
RISC-like complex (>670 kDa). W to A mutations in any two of
the three GW/WG repeats in P1 abolished both the VSR activity
and AGO1 binding, although wild-type and mutant P1 were
expressed at similar levels, indicating that AGO1 binding is
essential for the VSR activity (Giner et al., 2010). Using two
established assays based on coexpression of miRNA/siRNA-
sensor constructs and VSR, it was further shown that P1
inhibited the silencing activity of mature RISC preloaded with
either a host miRNA or viral siRNAs. As proposed by Giner and
colleagues, high-affinity binding of AGO1by P1may outcompete
an essential endogenous GW/WG-containing component of
RISC or prevent recognition of target RNA by complementary
siRNA loaded in the RISC.
Specific targeting of an antiviral AGO was also demonstrated
for an insect VSR (Nayak et al., 2010), protein 1A of Cricket paral-
ysis virus (CrPV) shown previously to suppress Ago2-mediated
RVI in Drosophila S2 cells (Wang et al., 2006). Direct interaction
of the Drosophila Ago-2 with 1A expressed from a transfected
plasmid was detected in S2 cells (Nayak et al., 2010). Binding
of Ago-2 by 1A inhibited in vitro slicing of mRNA by a siRNA-pro-
grammed RISC without disrupting RISC assembly (Figure 1).
Silencing activity of a preassembled RISC was also inhibited in
S2 cells by 1A expressed from a cotransfected plasmid (Nayak
et al., 2010).
It is worth noting here that the AGO-targeted VSR activities of
SPMMV P1, poleorviruses P0, and CrPV 1A proteins were all
characterized following overexpression from a transgene. Ideally
these activities would need to be verified in the context of virus
infection where expression of the VSR from the cognate viral
genome is also targeted by host RVI.
VSRs Targeting Other Protein Components of RNA
Silencing
Cauliflower mosaic virus (CaMV) contains a circular dsDNA
genome replicating through an RNA intermediate, the 35S
RNA. The dsRNA-binding protein 4 (DRB4) of A. thaliana and
the VSR P6 of CaMV have been shown to interact directly
(Haas et al., 2008) (Figure 1). Although all four of the Dicer-like
proteins (DCLs) of A. thaliana participate in the biogenesis of
CaMV-derived siRNAs, the predominant species of viral siRNAs
are 24 and 21 nucleotides in length and produced by DCL3 and
DCL4, respectively (Ruiz-Ferrer and Voinnet, 2009). Interaction
of DRB4 with DCL4 in A. thaliana is required for production
of the 21 nucleotide siRNAs that target the endogenous
trans-acting siRNA (ta-siRNA) loci, exogenous transgenes, and
CaMV. All of these silencing events are effectively suppressed
by P6 expressed either from a stably integrated transgene orCell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc. 13
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nuclear localization signals, and mutations that prevent nuclear
import abolish both the VSR activity and the translational activa-
tion of the viral polycistronic 35S RNA, an essential function
previously assigned to P6. Notably, Haas and colleagues engi-
neered a three-residue substitution in the nuclear localization
signal of P6 that abolished CaMV infectivity without significantly
altering the translational activation function of P6, indicating that
in the context of CaMV infection a new function of P6 is required.
However, further studies will be necessary to determine if the
VSR activity of P6 has a specific role in viral infection.
Tomato yellow leaf curl virus (TYLCV), a member of Geminivir-
idae, contains a small circular ssDNA genome. The SGS3 protein
from either A. thaliana or tomato has been shown to interact with
TYLCV VSR V2 protein (Glick et al., 2008). SGS3 is essential for
RDR6-dependent biogenesis of ta-siRNAs, transgene and viral
siRNAs. A recent study found that both SGS3 and V2 selectively
bind 50 overhang-containing dsRNA and that V2 outcompetes
SGS3 for binding to the dsRNA substrate in vitro (Fukunaga
and Doudna, 2009). Therefore, V2 may bind either SGS3 and/
or a dsRNA intermediate produced during slicing and inhibit
dsRNA synthesis by the RDR6 pathway (Figure 1).
VSRs Targeting RNA Components of RNA Silencing
Binding to the long dsRNA and siRNA was once thought to be
the main strategy of VSRs (Ruiz-Ferrer and Voinnet, 2009).
VSR B2 protein of the natural insect pathogen Flock house virus
(FHV) contains a novel dsRNA-binding domain and inhibits
processing of long dsRNA into siRNAs in vitro, which explains
why B2 suppresses RNAi only when it is expressed prior to
the introduction of long dsRNAs (Figure 1). B2 interacts with
the viral dsRNA replicative intermediates (vRI-dsRNA) in infected
Drosophila cells (Aliyari et al., 2008). Production of viral siRNAs
was dramatically suppressed by B2 during FHV infection, which
is most likely because B2 is in close proximity to the nascent
vRI-dsRNA following the recruitment of B2 to the viral replication
complex by an interaction with the viral RNA-dependent RNA
polymerase (Aliyari et al., 2008).
The VSR P19 of plant tombusviruses such as Cymbidium ring-
spot virus (CymRSV) selectively binds short dsRNA and can
sequester 21 nucleotide siRNA duplexes from being assembled
into holo-RISC in Drosophila cells (Lakatos et al., 2006).
However, P19-deficient mutant of CymRSV accumulates to
levels similar to wild-type virus in both protoplasts and the inoc-
ulated leaves and only exhibits defects in spreading out of the
vasculature bundles to invade the surrounding tissues in the
systemically infected leaves (Havelda et al., 2003), indicating
that P19 does not prevent RISC-mediated degradation of viral
RNAs. Dunoyer and colleagues found recently that P19 could
specifically sequester DCL4-dependent 21 nucleotide transgene
siRNAs in silencing-incipient cells and prevent them from
spreading cell to cell to induce RNA silencing in the neighboring
recipient cells (Figure 1) (Dunoyer et al., 2010). These findings
support an earlier hypothesis that P19 promotes systemic viral
infection by sequestering viral siRNA duplexes from spreading
out of the vasculature to immune neighboring cells against
CymRSV (Li and Ding, 2006).
A VSR encoded by sweet potato chlorotic stunt virus (SPCSV)
is a class 1 RNase III consisting of an RNase domain and14 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.a canonical dsRNA-binding domain (Cuellar et al., 2009). In addi-
tion to long dsRNA substrates, the viral RNase III also cleaved
siRNA duplexes of 21–24 nucleotides long into 14 bp fragments
in vitro. In transgenic plants, the viral RNaseIII suppresses RNA
silencing induced by the RDR6-dependent pathway but is inac-
tive when induction of RNA silencing does not depend on de
novo dsRNA synthesis by RDR6. Cleavage of viral siRNAs has
been proposed as the mechanism for the VSR of SPCSV.
However, available data do not exclude long dsRNA as possible
targets.
Does VSR Activity Play a Role in Mammalian
Viral Infection?
Many mammalian viruses encode a VSR (Li and Ding, 2006).
However, it is not entirely clear if the VSR activity has a specific
role in mammalian viral infection because rescue of VSR-defi-
cient mutant viruses in mammalian host cells defective in RNA
silencing is yet to be demonstrated. Using an indirect approach,
two recent studies (Qian et al., 2009; Schnettler et al., 2009)
investigated the role of VSR during infection of human immuno-
deficiency virus (HIV). HIV was reported to encode a putative
VSR, Tat (Bennasser et al., 2005), but this conclusion has been
debated by a subsequent study carried out by another lab (Lin
and Cullen, 2007). A known function of Tat is to enhance tran-
scription of HIV RNA from the integrated proviral DNA by binding
to an internal stem-loop structural element of HIV RNA. However,
HIV gene expression in infected cells requires a transcriptional
enhancer-independent activity of Tat, and this activity could be
substituted by two distinct plant VSRs: the tombusviral P19
and the NS3 protein of rice hoja blanca virus (Qian et al., 2009;
Schnettler et al., 2009). NS3 has the same affinity for siRNA
duplexes as P19, and neither sequesters long dsRNA, which in
vertebrates is recognized as a pathogen-associated molecular
pattern and activator of multiple innate immunity pathways.
Notably, NS3/P19 mutants defective in siRNA binding were
also unable to rescue HIV gene expression in infected mamma-
lian cells (Qian et al., 2009; Schnettler et al., 2009). These findings
suggest that HIV infection requires suppression of small RNA-
directed gene silencing, which is consistent with previous obser-
vations that knockdown of Dicer enhances virus accumulation in
mammalian host cells (Matskevich and Moelling, 2007; Otsuka
et al., 2007; Triboulet et al., 2007).
Future studies will be necessary to determine if Tat and other
mammalian VSRs target RNA silencing induced by small RNAs
of either viral or host origin. It is known that mammalian viral
infection can induce production of virus-derived miRNAs and
alter the expression profile of cellular miRNAs (Skalsky and
Cullen, 2010). Moreover, although early studies based on stan-
dard RNA sequencing protocols were not successful, a recent
survey in a wide range of mammalian host systems by deep
sequencing has identified low abundant virus-derived small
RNAs from several distinct RNA viruses (Parameswaran et al.,
2010). Notably, the newly cloned viral small RNAs contain
a subpopulation with features of siRNAs similar to those
detected in plant and invertebrate hosts, including approxi-
mately equal positive and negative strand ratios, pairs of siRNA
duplexes with one or two unpaired nucleotides at the 30 ends,
and association with AGO proteins in vivo (Parameswaran
et al., 2010). These studies provide experimental systems for
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virus-derived small RNAs in the RNA-based virus immunity.
VSR mechanisms and host targets identified from studies in
invertebrate and plant systems could provide useful guiding
principles for future mammalian studies.ACKNOWLEDGMENTS
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